These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 33421026)

  • 1. Temporal trends in coronary intervention strategies and the impact on one-year clinical events: data from a Japanese multi-center real-world cohort study.
    Sakamoto K; Sato R; Tabata N; Ishii M; Yamashita T; Nagamatsu S; Motozato K; Yamanaga K; Hokimoto S; Sueta D; Araki S; Fujisue K; Arima Y; Takashio S; Fujimoto K; Shimomura H; Tsunoda R; Hirose T; Sato K; Kikuta K; Sakaino N; Nakamura S; Yamamoto N; Matsumura T; Kajiwara I; Tayama S; Sakamoto T; Nakao K; Oshima S; Yamamoto E; Kaikita K; Tsujita K;
    Cardiovasc Interv Ther; 2022 Jan; 37(1):66-77. PubMed ID: 33421026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ischemic and Bleeding Events Among Patients With Acute Coronary Syndrome Associated With Low-Dose Prasugrel vs Standard-Dose Clopidogrel Treatment.
    Shoji S; Sawano M; Sandhu AT; Heidenreich PA; Shiraishi Y; Ikemura N; Ueno K; Suzuki M; Numasawa Y; Fukuda K; Kohsaka S
    JAMA Netw Open; 2020 Apr; 3(4):e202004. PubMed ID: 32239221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contemporary antiplatelet treatment in acute coronary syndrome patients undergoing percutaneous coronary intervention: 1-year outcomes from the GReek AntiPlatElet (GRAPE) Registry.
    Alexopoulos D; Xanthopoulou I; Deftereos S; Hamilos M; Sitafidis G; Kanakakis I; Pentara I; Vavouranakis M; Davlouros P; Hahalis G; Goudevenos J
    J Thromb Haemost; 2016 Jun; 14(6):1146-54. PubMed ID: 26990959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the safety and effectiveness of prasugrel and clopidogrel in younger population undergoing percutaneous coronary intervention: A retrospective study using a Japanese claims database.
    Hagiwara H; Fukuta H; Hashimoto H; Niimura T; Zamami Y; Ishizawa K; Kamiya T; Ohte N
    J Cardiol; 2021 Mar; 77(3):285-291. PubMed ID: 34074484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of prasugrel and clopidogrel-treated patients with acute coronary syndrome undergoing percutaneous coronary intervention: A propensity score-matched analysis of the Acute Myocardial Infarction in Switzerland (AMIS)-Plus Registry.
    Kurz DJ; Radovanovic D; Seifert B; Bernheim AM; Roffi M; Pedrazzini G; Windecker S; Erne P; Eberli FR
    Eur Heart J Acute Cardiovasc Care; 2016 Feb; 5(1):13-22. PubMed ID: 25614494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations Between Complex PCI and Prasugrel or Clopidogrel Use in Patients With Acute Coronary Syndrome Who Undergo PCI: From the PROMETHEUS Study.
    Chandrasekhar J; Baber U; Sartori S; Aquino M; Kini AS; Rao S; Weintraub W; Henry TD; Farhan S; Vogel B; Sorrentino S; Ge Z; Kapadia S; Muhlestein JB; Weiss S; Strauss C; Toma C; DeFranco A; Effron MB; Keller S; Baker BA; Pocock S; Dangas G; Mehran R
    Can J Cardiol; 2018 Mar; 34(3):319-329. PubMed ID: 29475531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent effect of prasugrel on acute phase resolution of intra-stent athero-thrombotic burden after percutaneous intervention to acute coronary syndrome.
    Tsukiyama Y; Kozuki A; Shinke T; Otake H; Kijima Y; Masano T; Nagoshi R; Shibata H; Takeshige R; Yanaka KI; Shite J; Hirata KI
    J Cardiol; 2018 Nov; 72(5):403-410. PubMed ID: 29731189
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Real-world observations with prasugrel compared to clopidogrel in acute coronary syndrome patients treated with percutaneous coronary intervention in the United States.
    Bae JP; Faries DE; Ernst FR; Lipkin C; Zhao Z; Moretz C; Lieu HD; Effron MB
    Curr Med Res Opin; 2014 Nov; 30(11):2207-16. PubMed ID: 25034466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment patterns and outcomes in patients undergoing percutaneous coronary intervention treated with prasugrel or clopidogrel (from the Swedish Coronary Angiography and Angioplasty Registry [SCAAR]).
    Damman P; Varenhorst C; Koul S; Eriksson P; Erlinge D; Lagerqvist B; James SK
    Am J Cardiol; 2014 Jan; 113(1):64-9. PubMed ID: 24169009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prescription Patterns of Clopidogrel, Prasugrel, and Ticagrelor After Percutaneous Coronary Intervention With Stent Implantation (from the NCDR PINNACLE Registry).
    Khalid U; Bandeali S; Jones PG; Virani SS; Hira R; Hamzeh I; Chan PS; Kleiman NS; Lakkis N; Alam M
    Am J Cardiol; 2019 Dec; 124(12):1807-1812. PubMed ID: 31668345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual Antiplatelet Therapy Guided by CYP2C19 Polymorphisms after Implantation of Second-Generation Drug-Eluting Stents for Management of Acute Coronary Syndrome.
    Ozawa T; Suda M; Ikegami R; Takano T; Wakasugi T; Yanagawa T; Tanaka K; Ozaki K; Hirono S; Minamino T
    Int Heart J; 2018 Jan; 59(1):21-26. PubMed ID: 29279531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiplatelet drug selection in PCI to vein grafts in patients with acute coronary syndrome and adverse clinical outcomes: Insights from the British Cardiovascular Intervention Society database.
    Sirker A; Kwok CS; Kontopantelis E; Johnson T; Freeman P; de Belder MA; Ludman P; Zaman A; Mamas MA
    Catheter Cardiovasc Interv; 2018 Oct; 92(4):659-665. PubMed ID: 29356278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term Safety and Mid-term Efficacy of Prasugrel Versus Clopidogrel in Patients Undergoing Percutaneous Coronary Intervention.
    Koyabu Y; Abe S; Sakuma M; Kanaya T; Obi S; Yoneda S; Toyoda S; Nakajima T; Inoue T
    Intern Med; 2019 Aug; 58(16):2315-2322. PubMed ID: 31118376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Individualising dual antiplatelet therapy after percutaneous coronary intervention: the IDEAL-PCI registry.
    Christ G; Siller-Matula JM; Francesconi M; Dechant C; Grohs K; Podczeck-Schweighofer A
    BMJ Open; 2014 Oct; 4(10):e005781. PubMed ID: 25361837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prasugrel (Efient®) with percutaneous coronary intervention for treating acute coronary syndromes (review of TA182): systematic review and economic analysis.
    Greenhalgh J; Bagust A; Boland A; Dwan K; Beale S; Fleeman N; McEntee J; Dundar Y; Richardson M; Fisher M
    Health Technol Assess; 2015 Apr; 19(29):1-130. PubMed ID: 25896573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of low-dose prasugrel on platelet reactivity and cardiac dysfunction in acute coronary syndrome patients requiring primary drug-eluting stent implantation: A randomized comparative study.
    Kitano D; Takayama T; Fukamachi D; Migita S; Morikawa T; Tamaki T; Kojima K; Mineki T; Murata N; Akutsu N; Sudo M; Hiro T; Hirayama A; Okumura Y
    Catheter Cardiovasc Interv; 2020 Jan; 95(1):E8-E16. PubMed ID: 30983087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging-guided PCI for event suppression in Japanese acute coronary syndrome patients: community-based observational cohort registry.
    Yamashita T; Sakamoto K; Tabata N; Ishii M; Sato R; Nagamatsu S; Motozato K; Yamanaga K; Sueta D; Araki S; Arima Y; Yamamoto E; Takashio S; Fujisue K; Fujimoto K; Shimomura H; Tsunoda R; Maruyama H; Nakamura N; Sakaino N; Nakamura S; Yamamoto N; Matsumura T; Kajiwara I; Tayama S; Sakamoto T; Nakao K; Oshima S; Kaikita K; Hokimoto S; Tsujita K;
    Cardiovasc Interv Ther; 2021 Jan; 36(1):81-90. PubMed ID: 32052349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship Between Platelet Reactivity and Ischemic and Bleeding Events After Percutaneous Coronary Intervention in East Asian Patients: 1-Year Results of the PENDULUM Registry.
    Nakamura M; Kadota K; Takahashi A; Kanda J; Anzai H; Ishii Y; Shibata Y; Yasaka Y; Takamisawa I; Yamaguchi J; Takeda Y; Harada A; Motohashi T; Iijima R; Uemura S; Murakami Y;
    J Am Heart Assoc; 2020 May; 9(10):e015439. PubMed ID: 32394794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of prasugrel vs clopidogrel and outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention in contemporary clinical practice: Results from the PROMETHEUS study.
    Baber U; Sartori S; Aquino M; Kini A; Kapadia S; Weiss S; Strauss C; Muhlestein JB; Toma C; Rao SV; DeFranco A; Poddar KL; Chandrasekhar J; Weintraub W; Henry TD; Bansilal S; Baker BA; Marrett E; Keller S; Effron M; Pocock S; Mehran R
    Am Heart J; 2017 Jun; 188():73-81. PubMed ID: 28577683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prasugrel use and clinical outcomes by age among patients undergoing PCI for acute coronary syndrome: from the PROMETHEUS study.
    Chandrasekhar J; Baber U; Sartori S; Aquino M; Moalem K; Kini AS; Rao SV; Weintraub W; Henry TD; Vogel B; Ge Z; Muhlestein JB; Weiss S; Strauss C; Toma C; DeFranco A; Claessen BE; Keller S; Baker BA; Effron MB; Pocock S; Dangas G; Kapadia S; Mehran R
    Clin Res Cardiol; 2020 Jun; 109(6):725-734. PubMed ID: 31915997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.